US Stock MarketDetailed Quotes

TRVI Trevi Therapeutics

Watchlist
  • 2.775
  • -0.125-4.31%
Trading Jul 17 13:16 ET
195.46MMarket Cap-8161P/E (TTM)

Trevi Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Trevi Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 7, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.11

-83.33%
Analyst Rating

Strong Buy

Jul 9, 2024

Trevi Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 7, 20242024/Q10.000 / 0.000--
Mar 20, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 7, 20242024/Q10.000 / 0.000--
Mar 20, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Trevi Therapeutics Earnings Reports

  • Trevi Therapeutics | 10-Q: Quarterly report

    May 7 16:17 ET

  • Trevi Therapeutics | 10-K: Annual report

    Mar 20 16:14 ET

  • Trevi Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 16:13 ET

  • Trevi Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 16:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 9, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg